Diversified Trust Co Has $512,000 Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

Diversified Trust Co boosted its holdings in ICU Medical, Inc. (NASDAQ:ICUI) by 32.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 3,301 shares of the medical instruments supplier’s stock after acquiring an additional 805 shares during the quarter. Diversified Trust Co’s holdings in ICU Medical were worth $512,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Hexagon Capital Partners LLC lifted its stake in shares of ICU Medical by 162.7% in the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP increased its holdings in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 100 shares during the last quarter. Venturi Wealth Management LLC lifted its stake in ICU Medical by 1,510.0% in the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier’s stock valued at $59,000 after buying an additional 302 shares during the period. Point72 Hong Kong Ltd bought a new position in ICU Medical during the 3rd quarter worth approximately $72,000. Finally, GAMMA Investing LLC grew its holdings in ICU Medical by 83.6% during the third quarter. GAMMA Investing LLC now owns 571 shares of the medical instruments supplier’s stock valued at $104,000 after purchasing an additional 260 shares during the period. 96.10% of the stock is owned by institutional investors.

ICU Medical Stock Performance

Shares of ICU Medical stock opened at $154.35 on Friday. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03. The firm has a market cap of $3.78 billion, a price-to-earnings ratio of -33.77 and a beta of 0.63. ICU Medical, Inc. has a one year low of $86.80 and a one year high of $196.26. The stock’s 50-day moving average is $163.34 and its 200-day moving average is $157.00.

Insider Buying and Selling at ICU Medical

In related news, CEO Vivek Jain sold 1,373 shares of ICU Medical stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $155.48, for a total value of $213,474.04. Following the sale, the chief executive officer now owns 104,593 shares of the company’s stock, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Christian B. Voigtlander sold 1,430 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total value of $225,940.00. The disclosure for this sale can be found here. In the last quarter, insiders have sold 29,737 shares of company stock worth $4,941,832. Corporate insiders own 6.70% of the company’s stock.

Wall Street Analyst Weigh In

ICUI has been the subject of several research analyst reports. Jefferies Financial Group raised shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target for the company in a report on Wednesday, December 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. KeyCorp boosted their price objective on ICU Medical from $198.00 to $209.00 and gave the company an “overweight” rating in a research report on Wednesday, November 13th. Finally, StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $199.67.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.